InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,700.96
(
-0.01%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
78.70
(
0.00%
)
Bitcoin
62,866.46
(
0.66%
)

Replies to post #90718 on Biotech Values

Replies to #90718 on Biotech Values
icon url

rkrw

02/17/10 2:51 PM

#90720 RE: genisi #90718

In other words, 4 years before generic copaxone? :)
icon url

DewDiligence

12/09/10 4:26 AM

#110536 RE: genisi #90718

The GALA study of thrice-weekly Copaxone is now enrolling patients; top-line results are expected in Nov 2012:

http://clinicaltrials.gov/ct2/show/NCT01067521